Antitumor Efficacy
Antitumor Efficacy - Related Videos
03:59
In Vivo Antitumor Efficacy Analysis of PDT: A Technique to Determine the Phototoxic Potential of a Photosensitizer in Tumor Bearing Mice
0 Views •
2023
Photodynamic therapy (PDT) is a non-invasive and non-surgical method for lung cancer treatment. Photosensitizers selectively accumulate in tumor tissue and lead to tumor cell death in the presence of oxygen and the proper wavelength of light. This video describes the in vivo anti-tumor efficacy analysis using photosensitizer containing nanoparticles in a tumor-bearing mouse, to determine the phototoxic potential of the photosensitizer.
09:57
Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles
0 Views •
Cited by 1 •
2021
A standard protocol is described to study the antitumor activity and associated toxicity of IL-1α in a syngeneic mouse model of HNSCC.
01:29
Self-Efficacy
0 Views •
2025
Self-efficacy is the belief in one's capacity to organize and execute actions necessary to manage prospective situations. This belief significantly influences how individuals approach goals, tasks, and challenges across different domains of life.Psychological and Educational ImpactsIndividuals with strong self-efficacy are more resilient in the face of difficulties. They are more likely to adopt effective problem-solving strategies, persist through obstacles, and regulate emotions such as...
03:44
Luciferase Assay to Study Efficacy of Antiparasitic Chemicals Against Parasites
0 Views •
2025
The video demonstrates the luciferase assay used to determine the efficacy of an antiparasitic chemical inhibitor against the intracellular pathogen Toxoplasma gondii. The study involves luciferase-expressing parasites invading the host cells to replicate and survive. The chemical inhibitor binds with the cysteine proteases of the parasite and inhibits replication. The luciferase activity detected is proportional to the fold changes in parasite growth, determining the drug's efficacy against...
09:02
A Method to Test the Efficacy of Handwashing for the Removal of Emerging Infectious Pathogens
0 Views •
Cited by 9 •
2017
Handwashing is widely recommended to prevent infectious disease transmission. However, there is little evidence on which handwashing methods are most efficacious at removing infectious disease pathogens. We developed a method to assess the efficacy of handwashing methods at removing microorganisms.
FAQs
Antitumor efficacy can arise through several distinct biological actions, including selective cytotoxicity, apoptosis induction, cell-cycle disruption, angiogenesis inhibition, and activation of antitumor immunity. These mechanisms do not provide interchangeable evidence: a treatment may reduce malignant-cell survival directly or alter the tumor environment and immune response. Identifying the dominant action helps bioengineers connect therapeutic design with observed performance.
Selective cytotoxicity indicates that an intervention acts preferentially against malignant cells rather than producing only a general toxic effect. This distinction helps researchers determine whether observed antitumor activity reflects purposeful therapeutic action. In bioengineering studies, examining selectivity alongside growth inhibition or cell elimination can clarify whether a drug-delivery system, biomaterial, nanoparticle, or engineered cell performs as intended.
Cellular, tissue, and animal models provide progressively different contexts for examining treatment performance. Cellular systems can reveal direct effects on malignant cells, whereas tissue models introduce more relevant structural conditions, and animal models support evaluation in a broader biological setting. Comparing results across these models helps determine whether activity remains consistent beyond simplified experimental conditions.
Researchers first select an engineered intervention, such as a delivery system, biomaterial, nanoparticle, engineered cell, or tissue model, and then examine its effects in appropriate experimental models. Measurements may address tumor growth, malignant-cell elimination, disease progression, or specific mechanisms such as apoptosis and immune activation. Results are then used to compare performance and guide further therapeutic design.
These technologies are assessed not only for the activity of the therapeutic agent but also for whether they help the intervention reach tumors and function under relevant biological conditions. A delivery system or biomaterial can therefore be evaluated as part of the treatment’s overall performance. This approach connects engineering features with measurable antitumor outcomes and safety considerations.
Measuring antitumor efficacy supports comparisons among experimental technologies and helps researchers identify designs with stronger therapeutic performance. In bioengineering, the results can guide refinement of nanoparticles, engineered cells, biomaterials, drug-delivery systems, and tissue models. This evidence also contributes to translation by showing whether an intervention performs sufficiently under relevant conditions to support development of more precise cancer treatments.